NO20073809L - Viruspreparater og fremgangsmater - Google Patents

Viruspreparater og fremgangsmater

Info

Publication number
NO20073809L
NO20073809L NO20073809A NO20073809A NO20073809L NO 20073809 L NO20073809 L NO 20073809L NO 20073809 A NO20073809 A NO 20073809A NO 20073809 A NO20073809 A NO 20073809A NO 20073809 L NO20073809 L NO 20073809L
Authority
NO
Norway
Prior art keywords
virus
methods
serum
prepared
sulfate
Prior art date
Application number
NO20073809A
Other languages
English (en)
Norwegian (no)
Inventor
Gary Jim Calton
Rita Fishelevich
Original Assignee
Aurx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurx Inc filed Critical Aurx Inc
Publication of NO20073809L publication Critical patent/NO20073809L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20073809A 2004-12-23 2007-07-20 Viruspreparater og fremgangsmater NO20073809L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/021,275 US7344839B2 (en) 2004-12-23 2004-12-23 Virus preparations and methods
PCT/US2005/041061 WO2006071372A1 (fr) 2004-12-23 2005-11-14 Préparations de virus et méthodes

Publications (1)

Publication Number Publication Date
NO20073809L true NO20073809L (no) 2007-09-21

Family

ID=36612151

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073809A NO20073809L (no) 2004-12-23 2007-07-20 Viruspreparater og fremgangsmater

Country Status (8)

Country Link
US (1) US7344839B2 (fr)
EP (1) EP1833989A4 (fr)
JP (1) JP2008525023A (fr)
KR (1) KR20070120088A (fr)
AU (1) AU2005322521A1 (fr)
CA (1) CA2592141A1 (fr)
NO (1) NO20073809L (fr)
WO (1) WO2006071372A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080294361A1 (en) * 2007-05-24 2008-11-27 Popp Shane M Intelligent execution system for the monitoring and execution of vaccine manufacturing
CA2733399C (fr) * 2008-08-11 2018-10-09 Sanofi Pasteur Biologics Co. Compositions et procedes de production de virus herpes alpha
BR112012026095A2 (pt) 2010-04-14 2015-09-15 Emd Millipore Corp métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE209738C (fr)
JPS5341202B2 (fr) * 1974-03-12 1978-11-01
US5837261A (en) * 1990-09-25 1998-11-17 Cantab Pharmaceuticals Research Limited Viral vaccines
US5665362A (en) * 1990-09-25 1997-09-09 Cantab Pharmaceuticals Research Limited Viral vaccines
JPH06234659A (ja) 1992-05-05 1994-08-23 Handai Biseibutsubiyou Kenkyukai 安定化生ワクチン
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production
CA2097019C (fr) 1992-06-04 2007-07-24 Philip J. Provost Procede de production d'un vaccin contenant les virus varicelle-zona attenues
US6013265A (en) * 1996-10-22 2000-01-11 University Of Maryland, Baltimore Vaccine composition for herpes simplex virus and methods of using
US6054131A (en) * 1998-01-16 2000-04-25 University Of Maryland Baltimore Vaccine composition for herpes simplex virus and method of using
GB9804632D0 (en) * 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
US6951752B2 (en) * 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen

Also Published As

Publication number Publication date
WO2006071372A1 (fr) 2006-07-06
EP1833989A1 (fr) 2007-09-19
US20060141566A1 (en) 2006-06-29
JP2008525023A (ja) 2008-07-17
EP1833989A4 (fr) 2009-01-21
KR20070120088A (ko) 2007-12-21
AU2005322521A1 (en) 2006-07-06
US7344839B2 (en) 2008-03-18
CA2592141A1 (fr) 2006-07-06

Similar Documents

Publication Publication Date Title
WO2021155243A8 (fr) Compositions d'immunisation contre le virus respiratoire
EP1427817B1 (fr) Multiplication de virus dans une culture cellulaire
BR0015846A (pt) Método para a produção de um vìrus e/ou proteìnas virais diferentes de adenovìrus ou proteìnas adenovirais, uso de uma célula humana, vìrus ou proteìna viral para uso em uma vacina obtenìvel por meio dos citados métodos e uso, célula humana kit para determinar a atividade de uma protease em uma amostra, uso de uma proteìna viral ou um vìrus, método para concentrar vìrus influenza em condições capazes de, pelo menos em parte,preservar a capacidade de infecção do vìrus, e, vìrus influenza infeccioso ou seus derivados.
BR9908424A (pt) Processo para purificar uma preparação de herpesvìrus
BRPI0518568A2 (pt) mÉtodo para produzir uma partÍcula do vÍrus da influenza replicativo sem o uso de vÍrus auxiliar, partÍcula de vÍrus da influenza replicativo, cÉlula, composiÇço, uso de uma composiÇço, mÉtodo para gerar proteÇço imunolàgica contra infecÇço de um indivÍduo com um vÍrus da influenza, e, Ácido nuclÉico
ATE479742T1 (de) Verfahren zur grosstechnischen herstellung von impfstoffen
DK0904351T3 (da) Dyreceller og fremgangsmåder til replikationen af influenzavirus
BRPI0407636A (pt) meio de cultura de células, linhagem de células animais, métodos para produzir um meio de cultura condicionado, células animais, uma cultura de células animais, vìrus em uma cultura de células animais, ou, de preferência, humanas diplóides dependentes de ancoragem, método para produzir uma vacina, e, população de vìrus
DK1349926T3 (da) Komplementerende cellelinier
WO2007048089A3 (fr) Systeme a plasmides multiples de production de virus de la grippe
WO2002036790A3 (fr) Vecteur de virus grippal destine a l'infection de cellules dendritiques
ES2733489T3 (es) Proceso de purificación de poliovirus a partir de cultivos celulares
DK0480949T3 (da) Fremstilling af virus og oprensning af virale kappeproteiner til vaccineanvendelse
NO20073809L (no) Viruspreparater og fremgangsmater
WO2002014481A1 (fr) Procede de culture extensive de lymphocytes t cytotoxiques specifiques de l'antigene
JPWO2002014481A1 (ja) 抗原特異的細胞傷害性ｔ細胞拡大培養方法
JP2009501901A5 (fr)
WO2005115448A3 (fr) Systeme multiplasmide pour la production d'un virus grippal
CN106727623B (zh) 海藻低聚糖在制备抗禽白血病病毒制剂中的应用
DE60143810D1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
Takemoto et al. Influence of acid polysaccharides on plaque formation by influenza A2 and B viruses
Trávníček et al. Subunits of oncornavirus high-molecular-weight RNA I. Stepwise conversion of 60 S AMV (avian myeloblastosis virus) RNA to subunits
CA2501220A1 (fr) Vaccins contre le virus du nil occidental
Yamamoto The effect of ion concentration and pH on the thermal stability of a canine adenovirus
US3629470A (en) Process for purification of animal rna viruses

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application